Clinical trial
A Phase II Study of Protracted Infusional 5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid
NCT00002470 is registered in ClinicalTrials.gov with Mid-Atlantic Oncology Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Protracted Infusional 5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid
- Lead sponsor
- Mid-Atlantic Oncology Program
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 1990
- Completion date
- January 31, 2004
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal carcinoid tumor, lung cancer